Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-related Wet Macular Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00725686
What this trial is testing

Study of PF-04523655 (REDD14NP) In Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (Wet AMD)

Who this might be right for
Age-Related Macular Degeneration
Quark Pharmaceuticals 54
Not applicableWithdrawnNCT01339949
What this trial is testing

Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV)

Who this might be right for
Wet Age-related Macular DegenerationAge-related Macular DegenerationAMD+2 more
Oraya Therapeutics, Inc.
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05210803
What this trial is testing

Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
AbbVie 116
Testing effectiveness (Phase 2)Study completedNCT01535950
What this trial is testing

Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age-elated Macular Degeneration (Wet AMD)Exudative Macular Degeneration
Novartis Pharmaceuticals 43
Testing effectiveness (Phase 2)Looking for participantsNCT05197270
What this trial is testing

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
4D Molecular Therapeutics 215
Not applicableStudy completedNCT02055612
What this trial is testing

Mobile Clinic - a Cross-sectional Epidemiological Survey

Who this might be right for
Age Related Macular Degeneration
Novartis Slovakia, s.r.o. 3,278
Not applicableStudy completedNCT01404845
What this trial is testing

Macular Pigment Density Evolution in Unilateral Wet AMD Versus Non AMD Patients With or Without Lutein and Zeaxanthine Supplementation

Who this might be right for
Exudative Age-related Macular Degeneration
Affordance 200
Large-scale testing (Phase 3)Not Yet RecruitingNCT07816315
What this trial is testing

Phase 3 Study of Intravitreal OLN324 in Adults With Neovascular (Wet) Age-related Macular Degeneration (nAMD) (OLN324-CP-04)

Who this might be right for
Wet Age Related Macular Degeneration
Ollin Biosciences, Inc. 500
Testing effectiveness (Phase 2)Study completedNCT00935883
What this trial is testing

Complement Inhibition With Eculizumab for the Treatment of Non-Exudative Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
Philip J. Rosenfeld, MD, PhD 60
Large-scale testing (Phase 3)Study completedNCT03823287
What this trial is testing

Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)

Who this might be right for
Wet Macular Degeneration
Hoffmann-La Roche 671
Testing effectiveness (Phase 2)Ended earlyNCT00094120
What this trial is testing

MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With "Wet" Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Genaera Corporation 60
Testing effectiveness (Phase 2)Looking for participantsNCT07185841
What this trial is testing

Safety and Efficacy of Oral HX9428 Tablets in Subjects With Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration (AMD)
Fujian Haixi Pharmaceuticals Co., Ltd. 198
Testing effectiveness (Phase 2)Study completedNCT04486963
What this trial is testing

A Phase Ⅱ Clinical Study of Sanhuangjingshimingwan in Wet( Neovascular)Age-related Macular Degeneration(wAMD) Subjects

Who this might be right for
Age-related Macular Degeneration
Tasly Pharmaceutical Group Co., Ltd 78
Not applicableActive Not RecruitingNCT06518512
What this trial is testing

Automated Vision Assessment and Impairment Detection Through Gaze Analysis in Wet AMD Patients

Who this might be right for
Age-Related Macular DegenerationWet Age-related Macular Degeneration
Tan Tock Seng Hospital 128
Large-scale testing (Phase 3)UnknownNCT01255774
What this trial is testing

Serial Retinal Thickness Changes And Scotoma Size Measured With Lucentis Therapy

Who this might be right for
Age Related Macular Degeneration
The New York Eye & Ear Infirmary 20
Large-scale testing (Phase 3)Looking for participantsNCT04663750
What this trial is testing

Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).

Who this might be right for
Eye DiseasesMacular Degeneration, WetSub-Macular Hemorrhage
King's College Hospital NHS Trust 210
Testing effectiveness (Phase 2)Looking for participantsNCT07811726
What this trial is testing

NT-101 Topical in Patients With Wet AMD

Who this might be right for
Wet Age Related Macular Degeneration
NexThera Co., Ltd. 66
Not applicableUnknownNCT04640649
What this trial is testing

Prediction of Progression of Age-Related Macular Degeneration

Who this might be right for
Macular DegenerationMacular Degeneration, WetMacular Degeneration, Dry
University of Illinois at Chicago 278
Not applicableActive Not RecruitingNCT01115387
What this trial is testing

GARM II: A Study on the Genetics of Age-related Maculopathy

Who this might be right for
Age-related Macular DegenerationAge-related Maculopathy
University of California, Los Angeles 603
Testing effectiveness (Phase 2)Study completedNCT04993352
What this trial is testing

Evaluate the Safety and Efficacy of HLX04-O in Subjects With wAMD

Who this might be right for
Age Related Macular Degeneration
Shanghai Henlius Biotech 20
Next Page